Khumbu
Munich, DE · Founded 2021 · 4 employees on LinkedIn · 1 known investors
Khumbu is a Munich biotech building a physics-grounded world model for molecular biology to rethink drug discovery, with internal programs including diabetes and a Helmholtz Munich COPD collaboration. The legal entity is khumbu.ai Holding GmbH.
Founders & leadership
Khumbu was founded in 2021 by Grzegorz Popowicz, Hannes Nissen-Meyer, and Phillip Grass.
GP
Grzegorz PopowiczinCo-Founder & CSOStructural biologist; PhD under Nobel laureate Robert Huber. Group lead at Helmholtz Munich; CSO of Khumbu (LinkedIn shows CSO from June 2024; company site lists him as co-founder).
HN
Hannes Nissen-MeyerinCo-Founder & CEOPhD in mathematical physics (LMU Munich). Legal first name Johannes (impressum: Dr. Johannes Nissen-Meyer). Has led Khumbu’s platform since 2021.
PG
Phillip GrassCo-Founder & CTOPhD in mathematics/physics at the University of Munich; Kaggle prize winner. Principal architect of Khumbu’s AI drug-discovery stack.
HN
Hannes Nissen-Meyer, PhDin
Investors · 1
In the news
Frequently asked questions
- What does Khumbu do?
- Khumbu is a Munich biotech building a physics-grounded world model for molecular biology to rethink drug discovery, with internal programs including diabetes and a Helmholtz Munich COPD collaboration. The legal entity is khumbu.ai Holding GmbH.
- Who founded Khumbu?
- Khumbu was founded by Grzegorz Popowicz, Hannes Nissen-Meyer, Phillip Grass in 2021.
- Who are Khumbu's investors?
- Khumbu's investors include PICUS CAPITAL.
- Where is Khumbu headquartered?
- Khumbu is headquartered in Munich, DE.